Search | SBIR.gov

Would you like to sign up for e-mail updates?

Yes No

Home » Awards » CARDAX PHARMACEUTICALS, INC.

Company Information:

Name: CARDAX PHARMACEUTICALS, INC.

Address: CARDAX PHARMACEUTICALS, INC.
99-193 AIEA HEIGHTS DR, STE 400
AIEA, HI

Located in HUBZone: No

Woman-Owned: No

Minority-Owned: No

URL: N/A

Phone: N/A

Award Totals:

Program/Phase	Award Amount ($)	Number of Awards
SBIR Phase I	$314,438.00	1
SBIR Phase II	$944,270.00	1

Award List:

Heptax for Alcoholic Liver Disease

Award Year / Program / Phase: 2009 / SBIR / Phase I

Agency: HHS

Principal Investigator: Fredric J. Pashkow

Award Amount: $314,438.00

Abstract:

DESCRIPTION (provided by applicant): Alcoholic Liver Disease (ALD) is caused by excessive long term consumption of alcohol via increased oxidative stress, reduction of oxygen to liver tissue (hypoxia), altered fat metabolism, increased pro-inflammatory sig naling molecules (or cytokines), and… More

Heptax for Alcoholic Liver Disease

Award Year / Program / Phase: 2010 / SBIR / Phase II

Agency: HHS

Principal Investigator: Fredric J. Pashkow

Award Amount: $944,270.00

Abstract:

DESCRIPTION (provided by applicant): Alcoholic Liver Disease (ALD) is caused by excessive long term consumption of alcohol via increased oxidative stress, reduction of oxygen to liver tissue (hypoxia), altered fat metabolism, increased pro-inflammatory sig naling molecules (or cytokines), and… More